2 studies found for:    15800326 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Condition: Metastatic Cancer
Interventions: Biological: PG13-CEA_TCR (Anti-CEA TCR PBL);   Drug: Aldesleukin
2 Terminated
Has Results
Drosophila-generated CTL
Condition: Metastatic Cutaneous Melanoma
Interventions: Drug: fludarabine;   Drug: cyclophosphamide;   Drug: Drosophila-peptide pulsed Melanoma-reactive autologous CD8+ PBL;   Drug: Aldesleukin

Indicates status has not been verified in more than two years